AI Governance, SEC Disclosure, and Board Accountability

New research from Iterate.ai outlines why public company directors and senior leadership teams should treat AI governance as an active board-level responsibility—not a future compliance consideration.

Although AI-specific federal regulation is still developing, the SEC is already using existing rules around material risk, cybersecurity governance, internal controls, and public disclosure to evaluate how companies manage artificial intelligence. For public companies, AI oversight now intersects directly with disclosure accuracy, vendor risk, litigation exposure, and fiduciary duty.

Inside the research:

• Why AI disclosure standards are already relevant: The SEC is increasingly focused on whether companies describe AI-related risks and capabilities with specificity. Generic statements, aspirational language, or unsupported claims may create exposure if they do not reflect actual governance practices.
• How AI expands board oversight obligations:  As AI systems become embedded in pricing, lending, hiring, compliance, customer operations, and financial reporting, directors must be able to demonstrate that appropriate monitoring and escalation systems are in place for material AI risks.
• Why public AI tools can create legal and confidentiality risk: Recent legal developments show that using public AI platforms for sensitive legal, compliance, or regulatory work may jeopardize privilege and confidentiality protections if proper safeguards are not in place.
• Why vendor contracts are not enough: Enterprise AI agreements do not automatically ensure confidentiality, prevent model training, or preserve legal privilege. Boards and executive teams need evidence of how AI tools are configured, governed, monitored, and controlled.

Download the full white paper
Fill out the form to access the full research and learn the key questions every board should be able to answer about AI systems, SEC disclosures, committee oversight, third-party model dependencies, vendor controls, and privilege risk.

Companies that delay may be assuming regulators, plaintiffs’ attorneys, and institutional investors will wait for AI-specific rules before asking difficult questions. The current enforcement and litigation trajectory suggests that is a risky assumption.